arrow_back Civic Audit
Share share

Boosting Brain Tumor Research, Innovation, and Survivor Care (BRAIN Act)

This bill authorizes funding to accelerate research into brain tumors, including glioblastoma and CAR-T therapies, authorizing a total of $60 million annually for fiscal years 2026-2030 for these specific programs. It establishes reporting requirements for NIH-funded biospecimen collections to increase transparency. Furthermore, the act provides for a public awareness campaign regarding clinical trials and pilot programs regarding care for brain tumor survivors.
Key points
Authorization of appropriations for glioblastoma research ($50 million annually) and CAR-T team science awards ($10 million annually) for fiscal years 2026-2030.
Public awareness campaign regarding clinical trials and biomarker testing to increase knowledge among patients and health care providers.
Pilot programs to develop, study, or evaluate models for monitoring and caring for brain tumor survivors.
Reporting requirement for NIH-funded brain tumor biospecimen collections to make information accessible via a database.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 118_S_4739
Sponsor: Sen. Blumenthal, Richard [D-CT]
Process start date: 2024-07-23
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

BRAIN Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_4739.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-07-23.

What are the main provisions?

Key points include:

  • Authorization of appropriations for glioblastoma research ($50 million annually) and CAR-T team science awards ($10 million annually) for fiscal years 2026-2030.
  • Public awareness campaign regarding clinical trials and biomarker testing to increase knowledge among patients and health care providers.
  • Pilot programs to develop, study, or evaluate models for monitoring and caring for brain tumor survivors.
  • Reporting requirement for NIH-funded brain tumor biospecimen collections to make information accessible via a database.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Blumenthal, Richard [D-CT].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Public Investments